Uganda Securities Exchange
Quality Chemical Industries Ltd · CQCIL.UG
Quality Chemical Industries Ltd is a Uganda-based pharmaceutical manufacturer and a listed issuer on the Uganda Securities Exchange. The company manufactures and sells essential medicines with a historic focus on antiretroviral products for HIV treatment, artemisinin-based combination therapies for malaria, and medicines for hepatitis, with expansion into additional therapeutic areas. Its manufacturing base in Kampala gives the company a regional role in African pharmaceutical production, where availability, affordability, quality assurance, regulatory approvals, procurement contracts, and supply-chain reliability are central to the business model. Revenue can depend on public-sector procurement, donor-funded health programs, export registrations, local private-market demand, product mix, plant utilization, and compliance with pharmaceutical manufacturing standards. For investors, QCIL provides exposure to the development of local medicine manufacturing in Africa and demand for treatments addressing high-burden diseases. Key analysis points include product approvals, customer concentration, working capital, capacity expansion, quality systems, input sourcing, and policy support for local pharmaceutical production.
Fundamentals
| Metric (UGX, B) | 2013 2013 |
|---|---|
| Revenue Total Revenue | 90 |
| EBITDA | 14 |
| EBIT | 9 |
| Net income Net Income | 8 |
| Operating margin | 10% |
| Net margin | 9% |